Tencent Holdings

Sinovent, established in 2016, is a global biopharmaceutical company with headquarters in Suzhou, China, and offices in Beijing, China, and Boston, U.S.A. It specializes in developing advanced treatments for global healthcare challenges, with a focus on oncology, autoimmune diseases, and infectious diseases. Sinovent's portfolio comprises 12 products in various stages of development, leveraging its expertise in science, management, and finance to deliver innovative solutions to patients worldwide.

Forward is a startup focused on transforming healthcare delivery by incorporating advanced technologies that have been underutilized in the industry, such as sensors, mobile applications, and artificial intelligence. Founded in January 2016 by former executives from Google and Uber, Forward operates primary care clinics that emphasize personalized patient care. Through its mobile application and natural language processing system, the company enhances healthcare services, offering features like body scanning, genetic screening, real-time blood testing, and home monitoring of vital signs. These innovations empower patients to take control of their health, promote transparency, and foster better collaboration with their primary care physicians. Backed by prominent investors and entrepreneurs, Forward aims to redefine the patient experience in healthcare.

PetMedix Ltd is a veterinary biopharmaceutical company based in Hinxton, United Kingdom, that specializes in therapeutic drug discovery for pets. Founded in 2017, the company utilizes advanced scientific techniques to develop innovative antibody therapies aimed at improving the health and well-being of companion animals. PetMedix has created specialized platforms, including the Ky9 and Felyne transgenic mouse systems, which are designed to produce therapeutic-quality antibodies tailored for pets. This approach allows for the generation of a diverse repertoire of antibodies that mirrors the immune systems of companion animals, enabling veterinarians to administer safe and effective monoclonal antibody treatments. By applying over thirty years of expertise in human drug development to veterinary medicine, PetMedix is dedicated to enhancing the quality of life for pets through cutting-edge therapies.

Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative immunotherapeutics and vaccines aimed at treating and preventing infectious diseases and cancer. The company utilizes proprietary modified simian adenoviral vectors, specifically ChAdOx1 and ChAdOx2, along with the Modified Vaccinia Ankara (MVA) boost vector, both of which are designed to be safe and non-replicative in humans. This combination approach has demonstrated the ability to generate significantly higher levels of CD8+ T cells compared to other methodologies. Barinthus Biotherapeutics maintains a diverse pipeline that includes both clinical and preclinical therapeutic programs targeting solid tumors, viral infections, and prophylactic viral vaccines. In collaboration with the University of Oxford, the company co-invented a COVID-19 vaccine that has received approval for use in various regions worldwide.

QTC Care, founded in 2013 and headquartered in Shanghai, China, provides a range of medical services both domestically and internationally. The company specializes in preventative care, second opinions, multidisciplinary consultations, and personalized medical solutions tailored to meet the needs of high-end clients. With branches in major cities across the United States, Japan, Singapore, and Europe, QTC Care is dedicated to facilitating access to quality healthcare worldwide. It has established partnerships with over 600 renowned medical institutions and thousands of top-tier medical professionals, positioning itself as a leader in the globalization of medical services. The company's offerings include remote consultations, online diagnoses, and educational resources, particularly focused on cancer care, ensuring that patients receive comprehensive treatment and support from exceptional healthcare providers globally.

Tencent Trusted Doctors, a company established in early August 2018 upon the merger of Tencent Doctorwork and Trusted Doctors, is acquiring the start-up in an attempt to create a private healthcare network that provides both online and offline services through the so-called "celebrity effect".

Kenota Health is a company that specializes in the development of advanced diagnostic tools for allergy testing in humans. Their innovative point-of-care system streamlines the allergy testing process by utilizing a small blood sample, which is analyzed through their equipment to detect allergen sensitization within minutes. This non-invasive technology not only simplifies the testing procedure but also provides timely results directly to healthcare providers, enhancing the overall quality of diagnostic information available to physicians. By offering a safer and more cost-effective alternative to traditional allergy testing methods, Kenota Health aims to improve patient outcomes and facilitate better healthcare decision-making.

Kenota Health is a company that specializes in the development of advanced diagnostic tools for allergy testing in humans. Their innovative point-of-care system streamlines the allergy testing process by utilizing a small blood sample, which is analyzed through their equipment to detect allergen sensitization within minutes. This non-invasive technology not only simplifies the testing procedure but also provides timely results directly to healthcare providers, enhancing the overall quality of diagnostic information available to physicians. By offering a safer and more cost-effective alternative to traditional allergy testing methods, Kenota Health aims to improve patient outcomes and facilitate better healthcare decision-making.

iCarbonX is focused on creating a comprehensive ecosystem of digital health by integrating consumers' life data with artificial intelligence and biotechnology. The company, founded by a team with extensive experience in omics technology and data analysis from BGI Tech, aims to establish a leading data collection platform for health information in China. By gathering a wide range of data—including genomic, phenotypic, behavioral, social, and environmental factors—iCarbonX provides personalized health analyses and predictions. Its platform is designed to empower individuals to understand their genetic profiles and make informed decisions about their health and well-being, leveraging advanced data mining and machine learning techniques.

HomeHero, Inc. is a home care agency based in Santa Monica, California, specializing in non-medical services for families in need of support within their homes. Founded in 2013, the company provides a comprehensive array of services including personal care, companionship, meal preparation, light housekeeping, transitional care, care management, medication management, and transportation. HomeHero also implements safe transition home programs that facilitate secure rides and transitions for patients moving from hospitals to their homes. Additionally, the company offers The HomeHero Collaborative, a care management platform designed to enhance connectivity between hospitals, health plans, and home care services. HomeHero serves individual families across major California cities such as Los Angeles, San Diego, San Francisco, and Orange County, effectively bridging the gap between healthcare and home life through a combination of technology and compassionate care.